Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 17399
Country/Region: Zambia
Year: 2018
Main Partner: John Snow, Inc
Main Partner Program: NA
Organizational Type: Implementing Agency
Funding Agency: USAID
Total Funding: $19,903,870 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $2,162,543
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $810,954
Care: Pediatric Care and Support (PDCS) $946,112
Laboratory Infrastructure (HLAB) $1,000,000
Strategic Information (HVSI) $140,000
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $2,770,095
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $0
Testing: HIV Testing and Counseling (HVCT) $1,621,906
Sexual Prevention: Other Sexual Prevention (HVOP) $1,574,230
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $503,654
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $7,968,899
Treatment: Pediatric Treatment (PDTX) $405,477
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 2019 20,323
HTS_SELF 10-14, Female, Directly-Assisted 2019 200
HTS_SELF 10-14, Female, Unassisted 2019 399
HTS_SELF 10-14, Male, Directly-Assisted 2019 201
HTS_SELF 10-14, Male, Unassisted 2019 399
HTS_SELF 15-19, Female, Directly-Assisted 2019 600
HTS_SELF 15-19, Female, Unassisted 2019 598
HTS_SELF 15-19, Male, Directly-Assisted 2019 401
HTS_SELF 15-19, Male, Unassisted 2019 399
HTS_SELF 20-24, Female, Directly-Assisted 2019 803
HTS_SELF 20-24, Female, Unassisted 2019 796
HTS_SELF 20-24, Male, Directly-Assisted 2019 803
HTS_SELF 20-24, Male, Unassisted 2019 798
HTS_SELF 25-29, Female, Directly-Assisted 2019 803
HTS_SELF 25-29, Female, Unassisted 2019 803
HTS_SELF 25-29, Male, Directly-Assisted 2019 803
HTS_SELF 25-29, Male, Unassisted 2019 803
HTS_SELF 30-34, Female, Directly-Assisted 2019 803
HTS_SELF 30-34, Female, Unassisted 2019 803
HTS_SELF 30-34, Male, Directly-Assisted 2019 803
HTS_SELF 30-34, Male, Unassisted 2019 803
HTS_SELF 35-39, Female, Directly-Assisted 2019 803
HTS_SELF 35-39, Female, Unassisted 2019 803
HTS_SELF 35-39, Male, Directly-Assisted 2019 803
HTS_SELF 35-39, Male, Unassisted 2019 803
HTS_SELF 40-49, Female, Directly-Assisted 2019 803
HTS_SELF 40-49, Female, Unassisted 2019 801
HTS_SELF 40-49, Male, Directly-Assisted 2019 803
HTS_SELF 40-49, Male, Unassisted 2019 799
HTS_SELF 50+, Female, Directly-Assisted 2019 200
HTS_SELF 50+, Female, Unassisted 2019 196
HTS_SELF 50+, Male, Directly-Assisted 2019 200
HTS_SELF 50+, Male, Unassisted 2019 244
HTS_SELF Directly-Assisted 2019 10,076
HTS_SELF FSW, Directly-Assisted 2019 6,030
HTS_SELF FSW, Unassisted 2019 6,657
HTS_SELF MSM, Directly-Assisted 2019 3,019
HTS_SELF MSM, Unassisted 2019 3,696
HTS_SELF Unassisted 2019 10,247
HTS_SELF Unassisted - Other 2019 2,561
HTS_SELF Unassisted - Self 2019 5,125
HTS_SELF Unassisted - Sex Partner 2019 2,561
HTS_TST <5, Unknown Sex, Negative 2019 177
HTS_TST 1-9, Unknown Sex, Negative 2019 160
HTS_TST 10-14, Female, Negative 2019 25
HTS_TST 10-14, Female, Negative 2019 31
HTS_TST 10-14, Male, Negative 2019 14
HTS_TST 10-14, Male, Negative 2019 30
HTS_TST 15-19, Female, Negative 2019 126
HTS_TST 15-19, Female, Negative 2019 122
HTS_TST 15-19, Male, Negative 2019 32
HTS_TST 15-19, Male, Negative 2019 31
HTS_TST 20-24, Female, Negative 2019 113
HTS_TST 20-24, Female, Negative 2019 108
HTS_TST 20-24, Male, Negative 2019 65
HTS_TST 20-24, Male, Negative 2019 54
HTS_TST 25-29, Female, Negative 2019 61
HTS_TST 25-29, Female, Negative 2019 159
HTS_TST 25-29, Female, Negative 2019 79
HTS_TST 25-29, Female, Negative 2019 160
HTS_TST 25-29, Female, Negative 2019 591
HTS_TST 25-29, Female, Negative 2019 923
HTS_TST 25-29, Female, Negative 2019 114
HTS_TST 25-29, Female, Negative 2019 2,473
HTS_TST 25-29, Female, Negative 2019 55
HTS_TST 25-29, Female, Negative 2019 9
HTS_TST 25-29, Female, Negative 2019 917
HTS_TST 25-29, Female, Negative 2019 462
HTS_TST 25-29, Male, Negative 2019 67
HTS_TST 25-29, Male, Negative 2019 149
HTS_TST 25-29, Male, Negative 2019 83
HTS_TST 25-29, Male, Negative 2019 165
HTS_TST 25-29, Male, Negative 2019 589
HTS_TST 25-29, Male, Negative 2019 924
HTS_TST 25-29, Male, Negative 2019 127
HTS_TST 25-29, Male, Negative 2019 58
HTS_TST 25-29, Male, Negative 2019 10
HTS_TST 25-29, Male, Negative 2019 956
HTS_TST 25-29, Male, Negative 2019 462
HTS_TST 25-29, Male, Negative 2019 2,485
HTS_TST 30-34, Female, Negative 2019 61
HTS_TST 30-34, Female, Negative 2019 159
HTS_TST 30-34, Female, Negative 2019 79
HTS_TST 30-34, Female, Negative 2019 160
HTS_TST 30-34, Female, Negative 2019 588
HTS_TST 30-34, Female, Negative 2019 923
HTS_TST 30-34, Female, Negative 2019 114
HTS_TST 30-34, Female, Negative 2019 1,853
HTS_TST 30-34, Female, Negative 2019 55
HTS_TST 30-34, Female, Negative 2019 9
HTS_TST 30-34, Female, Negative 2019 917
HTS_TST 30-34, Female, Negative 2019 462
HTS_TST 30-34, Male, Negative 2019 67
HTS_TST 30-34, Male, Negative 2019 149
HTS_TST 30-34, Male, Negative 2019 83
HTS_TST 30-34, Male, Negative 2019 175
HTS_TST 30-34, Male, Negative 2019 587
HTS_TST 30-34, Male, Negative 2019 924
HTS_TST 30-34, Male, Negative 2019 127
HTS_TST 30-34, Male, Negative 2019 58
HTS_TST 30-34, Male, Negative 2019 10
HTS_TST 30-34, Male, Negative 2019 956
HTS_TST 30-34, Male, Negative 2019 462
HTS_TST 30-34, Male, Negative 2019 2,485
HTS_TST 35-39, Female, Negative 2019 61
HTS_TST 35-39, Female, Negative 2019 159
HTS_TST 35-39, Female, Negative 2019 79
HTS_TST 35-39, Female, Negative 2019 160
HTS_TST 35-39, Female, Negative 2019 569
HTS_TST 35-39, Female, Negative 2019 923
HTS_TST 35-39, Female, Negative 2019 114
HTS_TST 35-39, Female, Negative 2019 1,236
HTS_TST 35-39, Female, Negative 2019 55
HTS_TST 35-39, Female, Negative 2019 9
HTS_TST 35-39, Female, Negative 2019 917
HTS_TST 35-39, Female, Negative 2019 462
HTS_TST 35-39, Male, Negative 2019 67
HTS_TST 35-39, Male, Negative 2019 149
HTS_TST 35-39, Male, Negative 2019 83
HTS_TST 35-39, Male, Negative 2019 165
HTS_TST 35-39, Male, Negative 2019 558
HTS_TST 35-39, Male, Negative 2019 924
HTS_TST 35-39, Male, Negative 2019 127
HTS_TST 35-39, Male, Negative 2019 58
HTS_TST 35-39, Male, Negative 2019 10
HTS_TST 35-39, Male, Negative 2019 956
HTS_TST 35-39, Male, Negative 2019 462
HTS_TST 35-39, Male, Negative 2019 2,485
HTS_TST 40-49, Female, Negative 2019 61
HTS_TST 40-49, Female, Negative 2019 159
HTS_TST 40-49, Female, Negative 2019 79
HTS_TST 40-49, Female, Negative 2019 180
HTS_TST 40-49, Female, Negative 2019 564
HTS_TST 40-49, Female, Negative 2019 923
HTS_TST 40-49, Female, Negative 2019 114
HTS_TST 40-49, Female, Negative 2019 616
HTS_TST 40-49, Female, Negative 2019 55
HTS_TST 40-49, Female, Negative 2019 9
HTS_TST 40-49, Female, Negative 2019 917
HTS_TST 40-49, Female, Negative 2019 462
HTS_TST 40-49, Male, Negative 2019 67
HTS_TST 40-49, Male, Negative 2019 149
HTS_TST 40-49, Male, Negative 2019 83
HTS_TST 40-49, Male, Negative 2019 165
HTS_TST 40-49, Male, Negative 2019 555
HTS_TST 40-49, Male, Negative 2019 924
HTS_TST 40-49, Male, Negative 2019 127
HTS_TST 40-49, Male, Negative 2019 58
HTS_TST 40-49, Male, Negative 2019 10
HTS_TST 40-49, Male, Negative 2019 956
HTS_TST 40-49, Male, Negative 2019 462
HTS_TST 40-49, Male, Negative 2019 2,485
HTS_TST 50+, Female, Negative 2019 93
HTS_TST 50+, Female, Negative 2019 79
HTS_TST 50+, Male, Negative 2019 93
HTS_TST 50+, Male, Negative 2019 77
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 10,000
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 164,174
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 2,509
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 67
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 200
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 1,015
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 417
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 936
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 672
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 656
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 541
HTS_TST Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2019 1,017
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 503
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 114
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 336
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 84
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 277
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 165
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 215
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 219
HTS_TST Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 230
HTS_TST Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 60
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 212
HTS_TST Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 122
HTS_TST Service Delivery Point (Community) Other: 50+, Female, Negative 2019 165
HTS_TST Service Delivery Point (Community) Other: 50+, Male, Negative 2019 165
HTS_TST Service Delivery Point (Community) VCT Mod: 1-9, Negative 2019 645
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2019 104
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2019 57
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 999
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 306
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 922
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 462
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 691
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 615
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 61
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 2,582
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 3,567
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 213
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 1,026
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 168
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 92
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 280
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 117
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 286
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 168
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 242
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 158
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 1,930
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 311
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 170
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 159
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 39
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 144
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 89
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 114
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 110
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 11,883
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 2,605
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 1,412
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 2,001
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 507
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 1,699
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 10,934
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 1,203
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 1,141
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 4,025
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 11
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 6
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 10
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 12
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 14
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 29
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 4,821
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 784
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 435
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 1,914
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 505
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 1,609
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 967
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 1,243
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 1,204
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 2,011
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 11,251
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 11,251
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 3,666
HTS_TST_POS <5, Unknown Sex, Positive 2019 40
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 2
HTS_TST_POS 10-14, Female, Positive 2019 5
HTS_TST_POS 10-14, Male, Positive 2019 1
HTS_TST_POS 15-19, Female, Positive 2019 2
HTS_TST_POS 15-19, Female, Positive 2019 6
HTS_TST_POS 15-19, Male, Positive 2019 1
HTS_TST_POS 20-24, Female, Positive 2019 1
HTS_TST_POS 20-24, Female, Positive 2019 6
HTS_TST_POS 20-24, Male, Positive 2019 10
HTS_TST_POS 25-29, Female, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 50
HTS_TST_POS 25-29, Female, Positive 2019 6
HTS_TST_POS 25-29, Female, Positive 2019 17
HTS_TST_POS 25-29, Female, Positive 2019 208
HTS_TST_POS 25-29, Female, Positive 2019 75
HTS_TST_POS 25-29, Female, Positive 2019 12
HTS_TST_POS 25-29, Female, Positive 2019 197
HTS_TST_POS 25-29, Female, Positive 2019 6
HTS_TST_POS 25-29, Female, Positive 2019 4
HTS_TST_POS 25-29, Female, Positive 2019 66
HTS_TST_POS 25-29, Female, Positive 2019 33
HTS_TST_POS 25-29, Male, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 72
HTS_TST_POS 25-29, Male, Positive 2019 10
HTS_TST_POS 25-29, Male, Positive 2019 24
HTS_TST_POS 25-29, Male, Positive 2019 244
HTS_TST_POS 25-29, Male, Positive 2019 141
HTS_TST_POS 25-29, Male, Positive 2019 9
HTS_TST_POS 25-29, Male, Positive 2019 8
HTS_TST_POS 25-29, Male, Positive 2019 6
HTS_TST_POS 25-29, Male, Positive 2019 103
HTS_TST_POS 25-29, Male, Positive 2019 54
HTS_TST_POS 25-29, Male, Positive 2019 23
HTS_TST_POS 30-34, Female, Positive 2019 1
HTS_TST_POS 30-34, Female, Positive 2019 50
HTS_TST_POS 30-34, Female, Positive 2019 6
HTS_TST_POS 30-34, Female, Positive 2019 17
HTS_TST_POS 30-34, Female, Positive 2019 208
HTS_TST_POS 30-34, Female, Positive 2019 75
HTS_TST_POS 30-34, Female, Positive 2019 12
HTS_TST_POS 30-34, Female, Positive 2019 150
HTS_TST_POS 30-34, Female, Positive 2019 6
HTS_TST_POS 30-34, Female, Positive 2019 4
HTS_TST_POS 30-34, Female, Positive 2019 66
HTS_TST_POS 30-34, Female, Positive 2019 40
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 72
HTS_TST_POS 30-34, Male, Positive 2019 10
HTS_TST_POS 30-34, Male, Positive 2019 24
HTS_TST_POS 30-34, Male, Positive 2019 244
HTS_TST_POS 30-34, Male, Positive 2019 141
HTS_TST_POS 30-34, Male, Positive 2019 9
HTS_TST_POS 30-34, Male, Positive 2019 8
HTS_TST_POS 30-34, Male, Positive 2019 6
HTS_TST_POS 30-34, Male, Positive 2019 103
HTS_TST_POS 30-34, Male, Positive 2019 44
HTS_TST_POS 30-34, Male, Positive 2019 23
HTS_TST_POS 35-39, Female, Positive 2019 1
HTS_TST_POS 35-39, Female, Positive 2019 50
HTS_TST_POS 35-39, Female, Positive 2019 6
HTS_TST_POS 35-39, Female, Positive 2019 17
HTS_TST_POS 35-39, Female, Positive 2019 213
HTS_TST_POS 35-39, Female, Positive 2019 75
HTS_TST_POS 35-39, Female, Positive 2019 12
HTS_TST_POS 35-39, Female, Positive 2019 97
HTS_TST_POS 35-39, Female, Positive 2019 6
HTS_TST_POS 35-39, Female, Positive 2019 4
HTS_TST_POS 35-39, Female, Positive 2019 66
HTS_TST_POS 35-39, Female, Positive 2019 33
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 72
HTS_TST_POS 35-39, Male, Positive 2019 10
HTS_TST_POS 35-39, Male, Positive 2019 24
HTS_TST_POS 35-39, Male, Positive 2019 244
HTS_TST_POS 35-39, Male, Positive 2019 141
HTS_TST_POS 35-39, Male, Positive 2019 9
HTS_TST_POS 35-39, Male, Positive 2019 8
HTS_TST_POS 35-39, Male, Positive 2019 6
HTS_TST_POS 35-39, Male, Positive 2019 103
HTS_TST_POS 35-39, Male, Positive 2019 49
HTS_TST_POS 35-39, Male, Positive 2019 23
HTS_TST_POS 40-49, Female, Positive 2019 1
HTS_TST_POS 40-49, Female, Positive 2019 50
HTS_TST_POS 40-49, Female, Positive 2019 6
HTS_TST_POS 40-49, Female, Positive 2019 17
HTS_TST_POS 40-49, Female, Positive 2019 205
HTS_TST_POS 40-49, Female, Positive 2019 75
HTS_TST_POS 40-49, Female, Positive 2019 12
HTS_TST_POS 40-49, Female, Positive 2019 48
HTS_TST_POS 40-49, Female, Positive 2019 6
HTS_TST_POS 40-49, Female, Positive 2019 4
HTS_TST_POS 40-49, Female, Positive 2019 66
HTS_TST_POS 40-49, Female, Positive 2019 33
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 72
HTS_TST_POS 40-49, Male, Positive 2019 10
HTS_TST_POS 40-49, Male, Positive 2019 24
HTS_TST_POS 40-49, Male, Positive 2019 245
HTS_TST_POS 40-49, Male, Positive 2019 141
HTS_TST_POS 40-49, Male, Positive 2019 9
HTS_TST_POS 40-49, Male, Positive 2019 8
HTS_TST_POS 40-49, Male, Positive 2019 6
HTS_TST_POS 40-49, Male, Positive 2019 103
HTS_TST_POS 40-49, Male, Positive 2019 44
HTS_TST_POS 40-49, Male, Positive 2019 23
HTS_TST_POS 50+, Female, Positive 2019 10
HTS_TST_POS 50+, Male, Positive 2019 1
HTS_TST_POS 50+, Male, Positive 2019 13
HTS_TST_POS By Key Population: MSM, Positive 2019 1
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 1,359
HTS_TST_POS By Key Population: TG, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 173
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 173
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 117
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 217
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 187
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 286
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 420
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 1-9, Positive 2019 19
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2019 10
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 28
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 22
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Male, Positive 2019 8
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 1-9, Positive 2019 12
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 33
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 68
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 33
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Female, Positive 2019 44
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 44
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 202
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 282
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 65
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 24
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 21
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 31
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 66
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 111
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 8
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 286
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 22
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 40
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 1,428
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 102
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 168
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 81
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 97
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 17
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 45
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 99
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 43
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 95
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 145
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 111
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 141
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2019 46
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 8,035
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 8,035
PMTCT_ART Already on ART at beginning of current pregnancy 2019 1,099
PMTCT_ART New on ART 2019 1,359
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 2,458
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 18,042
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 1,965
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 493
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 2,458
PMTCT_EID Sum of Infant Age disaggregates 2019 2,458
PMTCT_STAT 25-29, Female 2019 5,421
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 299
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 4,835
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 287
PMTCT_STAT 30-34, Female 2019 3,486
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 299
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 2,983
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 205
PMTCT_STAT 35-39, Female 2019 2,705
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 238
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 2,247
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 220
PMTCT_STAT 40-49, Female 2019 2,684
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 46
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 2,300
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 338
PMTCT_STAT By Age (Numerator): 15-19 2019 27
PMTCT_STAT By Age (Numerator): 20-24 2019 3,715
PMTCT_STAT By Number of known positives: 15-19 2019 4
PMTCT_STAT By Number of known positives: 20-24 2019 213
PMTCT_STAT By Number of new negative: 20-24 2019 3,216
PMTCT_STAT By Number of new positives: 15-19 2019 23
PMTCT_STAT By Number of new positives: 20-24 2019 287
PMTCT_STAT Number of new ANC and L&D clients 2019 18,073
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 18,042
PMTCT_STAT_den 25-29, Female 2019 3,486
PMTCT_STAT_den 30-34, Female 2019 2,705
PMTCT_STAT_den 35-39, Female 2019 2,684
PMTCT_STAT_den By Age (Denominator): <15-19 2019 3,715
PMTCT_STAT_den By Age (Denominator): 10-14 2019 27
PMTCT_STAT_den By Age (Denominator): 20-24 2019 5,454
PMTCT_STAT_den By Age (Denominator): 50+ 2019 2
PP_PREV 25-29, Female 2019 4,896
PP_PREV 25-29, Male 2019 2,974
PP_PREV 30-34, Female 2019 3,028
PP_PREV 30-34, Male 2019 2,736
PP_PREV 35-39, Female 2019 2,687
PP_PREV 35-39, Male 2019 2,687
PP_PREV 40-49, Female 2019 2,679
PP_PREV 40-49, Male 2019 2,670
PP_PREV Age/sex: 10-14 Female 2019 2,466
PP_PREV Age/sex: 10-14 Male 2019 2,458
PP_PREV Age/sex: 15-19 Female 2019 2,897
PP_PREV Age/sex: 15-19 Male 2019 2,890
PP_PREV Age/sex: 20-24 Female 2019 12,472
PP_PREV Age/sex: 20-24 Male 2019 6,925
PP_PREV Age/sex: 50+ Female 2019 270
PP_PREV Age/sex: 50+ Male 2019 268
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 55,003
PP_PREV Sum of Age/Sex disaggregates 2019 30,646
PrEP_NEW 25-29, Female 2019 354
PrEP_NEW 25-29, Male 2019 634
PrEP_NEW 30-34, Female 2019 529
PrEP_NEW 30-34, Male 2019 108
PrEP_NEW 35-39, Female 2019 108
PrEP_NEW 35-39, Male 2019 23
PrEP_NEW 40-49, Female 2019 24
PrEP_NEW Female 20-24 2019 353
PrEP_NEW FSW 2019 1,215
PrEP_NEW MSM 2019 268
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 2,133
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 10
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 134
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 8
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 95
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 247
TB_PREV By Age/Sex (Numerator): <15, Female 2019 109
TB_PREV By Age/Sex (Numerator): <15, Male 2019 41
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 1,342
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 1,421
TB_PREV IPT, Life-long ART, New, Positive 2019 2,913
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 2,913
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 4,855
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 149
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 144
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 2,660
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 1,902
TB_PREV_den IPT, Life-long ART, New, Positive 2019 4,855
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 6
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 142
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 8
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 283
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 439
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 439
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 6
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 142
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 8
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 283
TX_CURR 25-29, Female, Positive 2019 3,428
TX_CURR 25-29, Male, Positive 2019 1,810
TX_CURR 30-34, Female, Positive 2019 4,531
TX_CURR 30-34, Male, Positive 2019 2,919
TX_CURR 35-39, Female, Positive 2019 4,114
TX_CURR 35-39, Male, Positive 2019 2,842
TX_CURR 40-49, Female, Positive 2019 5,762
TX_CURR 40-49, Male, Positive 2019 6,687
TX_CURR Age/Sex: <1 2019 636
TX_CURR Age/Sex: <1-9 2019 1,221
TX_CURR Age/Sex: 10-14 Female 2019 569
TX_CURR Age/Sex: 10-14 Male 2019 166
TX_CURR Age/Sex: 15-19 Female 2019 1,346
TX_CURR Age/Sex: 15-19 Male 2019 681
TX_CURR Age/Sex: 20-24 Female 2019 2,761
TX_CURR Age/Sex: 20-24 Male 2019 892
TX_CURR Age/Sex: 50+ Female 2019 3,125
TX_CURR Age/Sex: 50+ Male 2019 2,769
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 46,268
TX_CURR Sum of age/sex disaggregates 2019 2,027
TX_NEW 25-29, Female, Positive 2019 932
TX_NEW 25-29, Male, Positive 2019 682
TX_NEW 30-34, Female, Positive 2019 1,316
TX_NEW 30-34, Male, Positive 2019 916
TX_NEW 35-39, Female, Positive 2019 1,194
TX_NEW 35-39, Male, Positive 2019 867
TX_NEW 40-49, Female, Positive 2019 2,041
TX_NEW 40-49, Male, Positive 2019 2,086
TX_NEW Breastfeeding status 2019 1,585
TX_NEW By Age/Sex: <1 2019 5
TX_NEW By Age/Sex: 1-9 2019 480
TX_NEW By Age/Sex: 10-14 Female 2019 151
TX_NEW By Age/Sex: 10-14 Male 2019 18
TX_NEW By Age/Sex: 15-19 Female 2019 134
TX_NEW By Age/Sex: 15-19 Male 2019 143
TX_NEW By Age/Sex: 20-24 Female 2019 475
TX_NEW By Age/Sex: 20-24 Male 2019 221
TX_NEW By Age/Sex: 50+ Female 2019 793
TX_NEW By Age/Sex: 50+ Male 2019 1,932
TX_NEW FSW 2019 587
TX_NEW MSM 2019 542
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 14,386
TX_NEW Pregnancy status 2019 288
TX_NEW Sum of Age/Sex disaggregates 2019 3,867
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 44,655
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 1,784
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 1,299
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 23,899
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 17,673
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 532
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 409
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 4,590
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 3,537
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 9,068
TX_RET Numerator by Status: Breastfeeding 2019 465
TX_RET Numerator by Status: Pregnant 2019 1,745
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 10,473
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 602
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 456
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 5,216
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 4,199
TX_RET_den Denominator by Status: Breastfeeding 2019 518
TX_RET_den Denominator by Status: Pregnant 2019 2,002
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 45,305
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 1,884
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 1,433
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 24,370
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 17,618
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 45,305
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 45,305
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 45,305
VMMC_CIRC 30-34, Male 2019 1,774
VMMC_CIRC 35-39, Male 2019 1,771
VMMC_CIRC 40-49, Male 2019 1,424
VMMC_CIRC By Age: 0-60 days 2019 2
VMMC_CIRC By Age: 10-14 2019 1,734
VMMC_CIRC By Age: 15-19 2019 13,927
VMMC_CIRC By Age: 2 months - 9 years 2019 3
VMMC_CIRC By Age: 20-24 2019 8,396
VMMC_CIRC By Age: 25-29 2019 5,626
VMMC_CIRC By Age: 50+ 2019 391
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 34,648
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 35,048
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 30,074
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 24,448
Cross Cutting Budget Categories and Known Amounts Total: $3,400,000
Adolescent Girls and Young Women (AGYW) $2,500,000
Human Resources for Health $400,000
Condoms: Policy, Tools, and Services $500,000